ACTRN12619001518156尚未招募未知
itric Oxide on ExtraCorporeal Membrane Oxygenation – a randomised Trial in neonates and children (NECTAR trial).
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- Days 至 17 Years(—)
- 性别
- All
入选标准
- •1. All neonates and children < 18 years requiring ECMO for respiratory or cardiovascular dysfunction including extracorporeal cardiopulmonary resuscitation (eCPR)
- •2. Ability to obtain prospective consent or consent to continue from parents/guardian.
排除标准
- •1. Patients retrieved to PICU on ECMO who did not undergo randomisation during cannulation
- •2. Pre-existing methaemoglobinemia (MetHb>3%)
- •3. Anticipated inability to obtain parental consent (prospective consent or consent to continue)
- •4. Patients managed on ventricular assist device (VAD) only without an oxygenator present in the ECMO circuit
研究者
相似试验
招募中
不适用
nderstanding Extracorporal Membrane Oxygenation Induced Coaguloapathy – A Prospective Cohort Study in the Intensive Care Unit (EXTRICATE)In VV-ECMO patients with severe ARDSin VA-ECMO patients with cardiac arrest during ongoing resuscitation.DRKS00033769niversität Witten/Herdecke & Klinik Köln Merheim50
尚未招募
不适用
Pilot study investigating how Extracorporeal Membrane Oxygenation (ECMO) affects the major breathing muscles.Diaphragm atrophyECMOMusculoskeletal - Other muscular and skeletal disordersRespiratory - Other respiratory disorders / diseasesACTRN12616000944437Trent Donnelly20
招募中
不适用
Effect of Extracorporeal membrane oxygenation flow on Venous Congestion and abdominal Organ PerfusioJ80.0DRKS00032063niversitätsmedizin Göttingen70
已完成
不适用
ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory DiseaseCOVID-19JPRN-UMIN000039686Critical Care Research Group The Prince Charles Hospital20,000
已完成
不适用
Extracorporeal membrane oxygenation in patients with coronavirus disease 2019PCR-proven COVID-19, resulting in respiratory or cardiorespiratory insufficiency, refractory to conventional therapies.NL-OMON27273/A200
